Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
3 hedge funds and large institutions have $17.5M invested in Allergan plc in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
10% less capital invested
Capital invested by funds: $19.4M → $17.5M (-$1.93M)
57% less funds holding
Funds holding: 7 → 3 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JJ
JDC-JSC
New York
|
-$108M |
| 2 |
C
Cerebellum
San Francisco,
California
|
-$3.31M |
| 3 |
B
Barings
Charlotte,
North Carolina
|
-$862K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$28K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$1K |
AGN Hedge Fund Activity: Q3 2020 in Review
3 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2020, worth a combined $17.5M — down 9.9% from $19.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AGN and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was JDC-JSC, cutting an estimated $108M.
- 3 institutional investors held Allergan plc (AGN) as of Q3 2020, down from 7 in Q2 2020.
- Funds reported $17.5M of Allergan plc stock for Q3 2020, down 9.9% quarter-over-quarter.
- 0 funds opened new Allergan plc positions in Q3 2020 and 4 closed out, a net change of -4 holders.
- The largest Allergan plc seller in Q3 2020 was JDC-JSC, an estimated $108M sold.
Based on aggregated 13F filings for Q3 2020.